학술논문
Metabolic syndrome and arterial hypertension in the adult population of Romania: subanalysis of data from the SEPHAR IV study
Original Article
Original Article
Document Type
Academic Journal
Author
Source
Journal of Hypertension Research. Jan-June 2023, Vol. 9 Issue 1-2, p20, 7 p.
Subject
Language
English
Abstract
Introduction The worldwide prevalence of arterial hypertension is around 30% (31% in men and 30% in women), with 29% in the general population of the United States of America and [...]
Cardiovascular disease (CVD) continues to be the leading cause of mortality worldwide, with a significant increase in cardiovascular mortality trends in Eastern Europe. Metabolic syndrome (MS) represented the association between six cardiovascular risk factors: arterial hypertension, hyperinsulinemia, low levels of HDL-cholesterol, increased levels of triglycerides and conditions with insulin resistance as a common etiopathogenic link, arises from a combination of genetic and acquired factors that contribute to insulin resistance and chronic inflammation. We evaluated the prevalence of metabolic syndrome in a subgroup of 835 subjects who were included in SEPHAR IV (Study for Evaluation of Prevalence of Hypertension and Cardiovascular Risk in an Adult Population in Romania) from May 15 to July 20th 2021, and had complete data available for statistical analysis, using The National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (NCEP-ATP III) criteria: waist circumference >102 cm in men and >88 cm in women, hypertriglyceridemia ([greater than or equal to]150 mg/dL) or under specific treatment, low HDL-cholesterol (less than 40 mg/dL in men and less than 50 mg/dL in women), blood pressure readings higher than 130/85 mmHg, fasting blood glucose levels greater than 110 mg/dL or under specific treatment. Metabolic syndrome was present if at least three of the five criteria were present. The prevalence of NCEP-ATP III arterial hypertension criteria was significantly higher in men (70.5%) compared to women (55.1%), p Keywords: metabolic syndrome, arterial hypertension, SEPHAR, cardiovascular risk factors.
Cardiovascular disease (CVD) continues to be the leading cause of mortality worldwide, with a significant increase in cardiovascular mortality trends in Eastern Europe. Metabolic syndrome (MS) represented the association between six cardiovascular risk factors: arterial hypertension, hyperinsulinemia, low levels of HDL-cholesterol, increased levels of triglycerides and conditions with insulin resistance as a common etiopathogenic link, arises from a combination of genetic and acquired factors that contribute to insulin resistance and chronic inflammation. We evaluated the prevalence of metabolic syndrome in a subgroup of 835 subjects who were included in SEPHAR IV (Study for Evaluation of Prevalence of Hypertension and Cardiovascular Risk in an Adult Population in Romania) from May 15 to July 20th 2021, and had complete data available for statistical analysis, using The National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (NCEP-ATP III) criteria: waist circumference >102 cm in men and >88 cm in women, hypertriglyceridemia ([greater than or equal to]150 mg/dL) or under specific treatment, low HDL-cholesterol (less than 40 mg/dL in men and less than 50 mg/dL in women), blood pressure readings higher than 130/85 mmHg, fasting blood glucose levels greater than 110 mg/dL or under specific treatment. Metabolic syndrome was present if at least three of the five criteria were present. The prevalence of NCEP-ATP III arterial hypertension criteria was significantly higher in men (70.5%) compared to women (55.1%), p Keywords: metabolic syndrome, arterial hypertension, SEPHAR, cardiovascular risk factors.